Imatinib Mesylate

Imatinib Mesylate

4.6 Moderate risk

Imatinib Mesylate & Death

45.7%

of users reported Death

94.3%

also reported Death

75.0%

are men

Most common medical consequences

Death
94.3%
Severe reaction
5.7%

Have you experienced any negative side effects from this medication?

Imatinib Mesylate: general information

Most common side effects (4)

Most commonly affected ages

40 - 49 years
17.6%
50 - 59 years
<0.1%
60 - 69 years
22.5%
70 - 79 years
59.8%
On this page
Imatinib Mesylate & Death
Imatinib Mesylate: general information